<code id='904871F12A'></code><style id='904871F12A'></style>
      • <acronym id='904871F12A'></acronym>
      <center id='904871F12A'><center id='904871F12A'><tfoot id='904871F12A'></tfoot></center><abbr id='904871F12A'><dir id='904871F12A'><tfoot id='904871F12A'></tfoot><noframes id='904871F12A'>
      • <optgroup id='904871F12A'><strike id='904871F12A'><sup id='904871F12A'></sup></strike><code id='904871F12A'></code></optgroup>
        5. <b id='904871F12A'><label id='904871F12A'><select id='904871F12A'><dt id='904871F12A'><span id='904871F12A'></span></dt></select></label></b><u id='904871F12A'></u>
          <i id='904871F12A'><strike id='904871F12A'><tt id='904871F12A'><pre id='904871F12A'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / hotspot / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-08-21 08:24:23 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：Wikipedia   
                                        
                                      
                                      Page View：19
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Boston hospital trains restaurant workers on naloxone for overdoses
                                
                            
          Next article：  
                                      
                                          Dobbs anniversary: the lost opportunity of abortion as health care
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles